Tüdőrák: vizsgálatok itt: Belgium
127 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.
- No phaseTaking peopleMethylated Biomarkers of Smoking as a Selection Tool in Participants for Lung Cancer Screening
- Where
- Antwerp
- Életkor
- 50 év and over
- People
- 1000
- Run by
- University Hospital, Antwerp
See details and how to joinNCT07631624 - 1/2. fázisTaking peopleDose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
- Where
- Anderlecht, Edegem
- Életkor
- 18 év and over
- People
- 41 worldwide
- Run by
- OSE Immunotherapeutics
See details and how to joinNCT05751798 · EU 2024-514826-22-00 - 2. fázisTaking peopleMacrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients
- Where
- Jette
- Életkor
- 18 év and over
- People
- 20
- Run by
- Universitair Ziekenhuis Brussel
See details and how to joinNCT05933239 - 1/2. fázisBefejeződöttA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Leuven
- Életkor
- 12 év and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - 3. fázisNot yet taking people in BelgiumPhase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
- Where
- Leuven
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Nuvation Bio Inc.
See details and how to joinNCT07154706 · EU 2025-521971-29-00 - 1. fázisTaking peoplePhase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breast and colorectal cancers.
- Where
- Anderlecht
- Életkor
- 18 év and over
- People
- 76 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2023-510356-23-00 - 3. fázisTaking peopleEfficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
- Where
- Brussels, Edegem, Liège
- Életkor
- 18 év and over
- People
- 170 worldwide
- Run by
- Grupo Espanol de Tumores Neuroendocrinos
See details and how to joinNCT05918302 · EU 2022-502154-13-00 - 2/3. fázisTaking peopleA Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Adult Participants with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Where
- Hasselt, Leuven, Liège, Roeselare
- Életkor
- 18 év and over
- People
- 50 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2024-518586-10-00 - 1. fázisBefejeződöttPhase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
- Where
- Edegem
- Életkor
- 18 év and over
- People
- 304 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT04686305 · EU 2023-504949-31-00 - 1. fázisTaking peopleStudy to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
- Where
- Brussels, Edegem, Ghent, Leuven
- Életkor
- 18 év and over
- People
- 55 worldwide
- Run by
- DeuterOncology
See details and how to joinNCT05752552 - 4. fázisTaking peopleIncreasing the dosing interval of osimertinib in patients with EGFR mutated locally advanced or meta-static non-small cell lung cancer - OSI-SAVE
- Where
- Anderlecht, Bruxelles, Charleroi, Edegem, Gent, Jette, Leuven, Mons, Roeselare, Yvoir
- Életkor
- 18 év and over
- People
- 283 worldwide
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2024-514693-47-01 - No phaseNot yet taking people in BelgiumThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Brussels
- Életkor
- 18 év and over
- People
- 8000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - 2/3. fázisNot yet taking people in BelgiumPre- and post-treatment evaluation of lung function with Xenon-gas enhanced Dual-Energy CT-imaging in patients undergoing radiotherapy
- Where
- Jette
- Életkor
- 18 év and over
- People
- 40
- Run by
- UZ Brussel
See details and how to join2025-521559-22-00 - No phaseTaking peopleImmune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease
- Where
- Brussels
- Életkor
- Up to 80 év
- People
- 425
- Run by
- Université Catholique de Louvain
See details and how to joinNCT07384897 - No phaseTaking peoplePhysical Activity Coaching After Surgery for Patients With Resectable Non-small Cell Lung Cancer
- Where
- Bruges, Genk, Ghent, Hasselt, Roeselare
- Életkor
- 18 év and over
- People
- 90
- Run by
- University Hospital, Ghent
See details and how to joinNCT06057766 - 1. fázisNot yet taking people in BelgiumA phase 1b study of an autologous dendritic cell immunotherapy in combination with anti-programmed death-1 treatment in patients with metastatic non-small-cell lung cancer (DARE-LUNG)
- Where
- Gent
- Életkor
- 18 év and over
- People
- 64
- Run by
- Universitair Ziekenhuis Gent
See details and how to join2025-521577-13-00 - 2. fázisTaking peoplePreoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR)
- Where
- Hasselt
- Életkor
- 18 év and over
- People
- 20 worldwide
- Run by
- University Hospital, Essen
See details and how to joinNCT06784791 · EU 2023-505662-28-00 - No phaseTaking peoplePlasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules
- Where
- Genk
- People
- 350
- Run by
- Hasselt University
See details and how to joinNCT07087080 - 1/2. fázisTaking peopleFIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
- Where
- Anderlecht
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT06669117 · EU 2024-512760-64-00 - 3. fázisTaking peopleMaintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study
- Where
- Aalst, Anderlecht, Charleroi, Hasselt, Jette, La Louvière, Liège, Montigny-Le-Tilleul, Namur, Roeselare, Sint-Lambrechts-Woluwe, Yvoir
- Életkor
- 18 év and over
- People
- 1166 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT05692999 · EU 2023-503481-23-00 - No phaseTaking peopleMolecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors
- Where
- Brussels
- Életkor
- 18 év and over
- People
- 58
- Run by
- Jules Bordet Institute
See details and how to joinNCT06107608 - 1/2. fázisTaking peopleCisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer
- Where
- Brussels, Charleroi, Jolimont, Kortrijk, Liège, Mons, Roeselare
- Életkor
- 18 év and over
- People
- 32 worldwide
- Run by
- Inhatarget Therapeutics
See details and how to joinNCT06896890 - No phaseLeállítvaCardiopulmonary Toxicity of Thoracic Radiotherapy
- Where
- Leuven
- Életkor
- 18 év and over
- People
- 320 worldwide
- Run by
- University Medical Center Groningen
See details and how to joinNCT03978377 - No phaseTaking peoplePerioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study
- Where
- Ghent
- Életkor
- 18 év and over
- People
- 40
- Run by
- University Hospital, Ghent
See details and how to joinNCT05693363 - No phaseNot yet taking people in BelgiumUnderstanding Lung Cancer Related Risk Factors and Their Impact
- Where
- Liège
- Életkor
- 40 év to 80 év
- People
- 6160 worldwide
- Run by
- Biobizkaia Health Research Institute
See details and how to joinNCT06473870